TriMas (TRS) is a Consumer Cyclical company in the Packaging Containers industry. It has a market capitalization of $1.39B, a trailing price-to-earnings ratio of 23.3 and a free-cash-flow yield of 4.4%. Over the most recent reported fiscal year, revenue grew 2.4% and free cash flow per share grew 438.1%. Nama's AI scorecard rates it Hold, 5.0 out of 10. On 12-month momentum it ranks in the rising band of its market.
AI scorecard
Hold · 5.0/10
The sections balance. As of Nov 7, 2026.
Momentum
Rising · +20.3% over 12 months ex. last
Second-best fifth of its market on the past year's move.
Shariah screen
Not Shariah Compliant
At least one of the three ratios or the industry test failed.
Off its high
-15.0%
How far the last close sits under the highest price of the past five years.
Market cap
$1.39B
Trailing P/E
23.3
Price / book
1.0
Price / sales
2.0
FCF yield
4.4%
Dividend yield
0.4%
Gross margin
17.7%
Operating margin
-3.6%
Net margin
191.7%
Revenue growth (YoY)
+2.4%
Revenue growth (3-yr annual)
-9.9%
EPS growth (YoY)
+25.3%
FCF/share growth (YoY)
+438.1%
Beta
0.6
Exchange
NASDAQ
Sector
Consumer Cyclical
Industry
Packaging Containers
TRS earnings
Next report: Feb 25, 2027 (Q4 2026, EPS estimate $0.41).
Beat the EPS estimate in 4 of 4 recent quarters.
Quarter
Reported
EPS
Estimate
Surprise
Revenue
Q3 2026
Oct 29, 2026
$0.50
$0.48
+4.2%
—
Q2 2026
Jul 30, 2026
$0.52
$0.49
+6.1%
$174.58M
Q1 2026
Apr 30, 2026
$0.24
$0.19
+26.3%
$168.28M
Q4 2025
Feb 26, 2026
$0.40
$0.22
+81.8%
-$139.97M
TRS analyst price target
Median target $45.00 from 2 analysts, ranging $45.00 – $45.00.
Nama's AI scorecard currently rates TriMas Hold (5.0 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is TRS's P/E ratio?
TriMas trades at a trailing price-to-earnings ratio of 23.3.
When does TRS report earnings?
TriMas's next scheduled report is on Feb 25, 2027. Analysts expect EPS of $0.41.
What is the TRS price target?
The median analyst price target from 2 analysts is $45.00, with a range of $45.00 – $45.00.
Is TRS Shariah compliant?
Nama's AAOIFI-style screen reads TriMas as Not Shariah Compliant. At least one of the three ratios or the industry test failed.